This Slide: #25 of 100 |
Slide #25. Solanbridge Group Inc. — Colorado Medical Marijuana Product Producer
Acquirer:
Solanbridge Group Inc. (SLNX)
Acquiree:
Colorado Medical Marijuana Product Producer
Details:
Solanbridge Group Inc. (OTC: SLNX) is in the final negotiations to acquire a Colorado health product producer whose products are derived from naturally occurring cannabinoids and, in particular, cannabidiol (CBD). CBD is related to tetrahydrocannabinol (the psychoactive constituent of the cannabis plant). CBD possesses no psychoactive properties and therefore is a ready for market marijuana based ingredient. The negotiations for the acquisition are in their final stages and we should have an announcement in the next week or two.
Colorado Medical Marijuana Product Producer: PRIVATE
Open the DNAD Page at The Online Investor (in a new window) »
Free DNAD Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |